Trial intelligence / Profile preview

Dexamethasone for Obstructive Sleep Apnea in Children

NCT05638087Phase 3Completed

Sponsor
SickKids
Start
Oct 2022
Primary completion
Jul 2024
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in obstructive sleep apnea (OSA) comparing Dexamethasone Treatment with Placebo Treatment (2 arms). Primary endpoint: Obstructive apnea-hypopnea index. Started Oct 2022; status: completed.

02

Drugs

dexamethasone
03

Conditions

obstructive sleep apnea (OSA)

Beyond the preview

Go deeper on NCT05638087.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05638087.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call